AMEX · Medical - Instruments & Supplies
Milestone Scientific, Inc. (MLSS) Stock
$0.35
-2.78%
AMEX: MLSS
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026
GlobeNewswire · Jul 15, 2026
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY
GlobeNewswire · Jul 1, 2026
Milestone Scientific Strengthens Board to Support Next Phase of Growth
GlobeNewswire · Jun 25, 2026
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
GlobeNewswire · May 27, 2026
Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ...
GuruFocus.com · May 14, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held16.06%
Institutions Held5.11%
Institutions Float Held6.09%
Peer Comparison
About Milestone Scientific, Inc.
Milestone Scientific, Inc. is led by CEO Eric C. Hines, publicly traded since 1995.
Milestone Scientific, Inc. (MLSS) stock trades at $0.35 with a market capitalization of $30.96M. The stock is valued at a price-to-earnings (P/E) ratio of -7.97, price-to-book of 10.20, price-to-sales of 3.57. Over the past 52 weeks the stock has ranged between $0.22 and $0.60, and currently trades 41.7% below its 52-week high.
On profitability, Milestone Scientific, Inc. generates a return on equity (ROE) of -149.08%, return on capital employed of -103.88%, an operating margin of -50.84%, a net profit margin of -43.98%.